Yuval Malka

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 3

Top Topics

Pluripotent Stem Cells

Small Cell Lung Cancer

Transcription Factor

Top Venues

Science (New York, N.Y.)

The Journal of experimental medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Nicolaas J Boon, Rafaela A Oliveira, Pierre-René Körner, Adva Kochavi, Sander Mertens, Yuval Malka, Rhianne Voogd, Suzanne E M van der Horst, Maarten A Huismans, Lidwien P Smabers, Jonne M Draper, Lodewyk F A Wessels, Peter Haahr, Jeanine M L Roodhart, Ton N M Schumacher, Hugo J Snippert, Reuven Agami, Thijn R Brummelkamp
DNA damage induces p53-independent apoptosis through ribosome stalling. Science (New York, N.Y.) 384 (6697) (2024)
Nicolaas J Boon, Rafaela A Oliveira, Pierre-René Körner, Adva Kochavi, Sander Mertens, Yuval Malka, Rhianne Voogd, Suzanne E M van der Horst, Maarten A Huismans, Lidwien P Smabers, Jonne M Draper, Lodewyk F A Wessels, Peter Haahr, Jeanine M L Roodhart, Ton N M Schumacher, Hugo J Snippert, Reuven Agami, Thijn R Brummelkamp
DNA damage induces p53-independent apoptosis through ribosome stalling. Science (New York, N.Y.) 384 (6697) (2024)
Jinhyuk Bhin, Julia Yemelyanenko, Xue Chao, Sjoerd Klarenbeek, Mark Opdam, Yuval Malka, Liesbeth Hoekman, Dinja T Kruger, Onno B Bleijerveld, Chiara S Brambillasca, Justin Sprengers, Bjorn Siteur, Stefano Annunziato, Matthijs J van Haren, Nathaniel I Martin, Marieke van de Ven, Dennis Peters, Reuven Agami, Sabine C Linn, Epie Boven, A F Maarten Altelaar, Jos Jonkers, Daniel Zingg, Lodewyk F A Wessels
MYC is a clinically significant driver of mTOR inhibitor resistance in breast cancer. The Journal of experimental medicine 220 (11) (2023)